Two established activities of the multifunctional human hepatitis B virus X-protein are its transactivating and pro-apoptotic potential. We analysed whether X-proteins from other orthohepadnaviruses and the newly discovered avihepadnaviral X-proteins have similar functions as HBx. Previously, we have shown that HBx suppresses oncogenic transformation of primary rat embryo fibroblasts (REF) by induction of apoptosis. Using this system, we found that the wildtype X-proteins of woodchuck, ground squirrel, arctic squirrel and woolly monkey hepatitis B virus exhibit similar levels of proapoptotic activity as HBx, whereas mutants with carboxyterminal deletions were severely impaired in this activity. A strong correlation between the pro-apoptotic and transactivating abilities of the mammalian Xproteins was found. The newly discovered avihepadnaviral X-like proteins showed similar and Raf-MAPK pathway-dependent transactivating abilities and induced apoptosis in the REF-assay. Our data indicate that the transactivating and pro-apoptotic activities reside in the carboxyterminal half of orthohepadnaviral X and are conserved in avihepadnaviral X-proteins.
Introduction
The family of Hepadnaviridae is classified into two genera, Orthohepadnavirus which infects mammals and Avihepadnavirus whose natural hosts are birds. The human hepatitis B virus (HBV) was the first member of the orthohepadnaviruses to be discovered (Dane et al., 1970) , followed by the hepatitis B virus of the woodchuck (WHV) (Summers et al., 1978) , the ground squirrel (GSHV) (Marion et al., 1980) , arctic squirrel (ASHV) (Testut et al., 1996) and recently, the woolly monkey (WMHBV) (Lanford et al., 1998) . New additional primate hepadnavirus isolates from chimpanzee, orang-utan, gorilla and gibbon have been described (Grethe et al., 2000; Hu et al., 2000; Lanford et al., 2000; Macdonald et al., 2000; Norder et al., 1996; Takahashi et al., 2000; Warren et al., 1999) . They seem to be new genotypes of HBV in addition to the human genotypes A -G. The avihepadnaviruses include isolates from duck (DHBV) (Mason et al., 1980) , grey heron (HHBV) (Sprengel et al., 1988) , white stork (STHBV) (Pult et al., 2001) , ross goose (RGHBV, GenBank accession number M95589) and snow goose (SGHBV) (Chang et al., 1999) .
The two genera show very similar genetic organisation and virus replication but differ in course and outcome of infection. While infection of birds with hepadnaviruses usually results in mild hepatitis (Marion et al., 1984) , mammalian hepadnaviruses often cause acute and chronic hepatitis. The latter is associated with development of hepatocellular carcinoma (HCC) in 100% of perinatally infected woodchucks (Popper et al., 1987) , 7 -20% of ground squirrels (Marion et al., 1986) and an over 100-fold increased risk for liver cancer in man (Beasley et al., 1981) . In contrast to WHV-associated HCC-development which can mostly be attributed to insertional mutagenesis leading to overexpression of myc-family oncogenes, the mechanism is much less clear with HBV . The absence of HCC development in avihepadnaviral hosts has until recently been attributed to the lack of an X-open reading frame in the avihepadnaviruses.
Experimental evidence points to a role of the enigmatic hepatitis B virus X-protein (HBx) in HBVassociated HCC development. Several groups have demonstrated a weak transforming or cotransforming activity of HBx in immortalized cell lines (Kim et al., 2001; Oguey et al., 1996; Seifer et al., 1991; Shirakata et al., 1989) and in HBx-transgenic mice (Kim et al., 1991; Slagle et al., 1996; Terradillos and Billet, 1997; Yu et al., 1999) . Besides this transforming activity, a large variety of functions has been described for HBx, two of the better established being its transactivating and its pro-apoptotic properties. Transactivation seems to rely mainly on the activation of cytoplasmic signaling cascades, the best studied being the RasRaf-MAPK, Src and protein kinase C (PKC) pathways (for review : Murakami, 1999) . This activation may be linked by alteration of cytosolic calcium levels (Bouchard et al., 2001) . But transactivation may also be effected by interaction of HBx with nuclear transcription factors or other components of the transcription machinery (reviewed in Andrisani and Barnabas, 1999) . Expression of HBx can either sensitize cells to apoptotic stimuli or directly induce apoptosis (Bergametti et al., 1999; Chirillo et al., 1997; Kim et al., 1998; Schuster et al., 2000; Shintani et al., 1999; Sirma et al., 1999; Su and Schneider, 1997; Takada et al., 1999; Terradillos et al., 1998) but also promotes cell survival (Diao et al., 2001; Elmore et al., 1997; Gottlob et al., 1998a; Shih et al., 2000; Wang et al., 1995) depending on cellular status.
All mammalian hepadnavirus genomes possess an X open reading frame whose expression is essential for the establishment of infection as shown in the woodchuck model (Chen et al., 1993; Zoulim et al., 1994) . The different mammalian hepadnaviral Xproteins have limited sequence identity to HBx of only 40 -50% in the rodent viruses. Recently, the expression of an avihepadnaviral X-like ORF in vivo and in vitro has been described for DHBV whose existence had been previously predicted by Feitelson and Miller (1988) . The avihepadnaviral Xproteins of HHBV and DHBV have an even lower sequence identity of only about 20% compared to mammalian hepadnaviruses Netter et al., 1997) . Transcriptional transactivation activity of the DHBV X-like protein similar to HBx has been demonstrated recently but it is not known whether DHBx has also similar pro-apoptotic functions. This information is also lacking for some of the recently identified orthohepadnaviruses. Since the X-proteins appear to play a role in hepatocellular carcinoma development and appear essential for establishment of chronic infection, it is of interest to analyse whether all hepadnaviral X-proteins including those of the avian hepadnaviruses are functionally identical. Whatever the answer to this open question, this information may uncover the contribution of the X-proteins in disease development in different hosts and by different hepadnaviruses.
Previously, we have shown that HBx suppresses oncogenic transformation of primary rat embryo fibroblasts (REF) by induction of apoptosis (Schuster et al., 2000) . In the oncogene complementation assay used, primary rat embryo fibroblasts are transfected with two cooperating oncogenes and after 14 days in culture, transformed cells become visible as foci and can be counted (Land, 1995) . Expression of HBx resulted in a strong suppression of focus formation which could be partially relieved by additional cotransfection of the apoptosis inhibitors Bcl-2 and E1B. Here we report that ortho-and avihepadnaviral X-proteins have very similar pro-apoptotic and also transactivating properties.
Results

X-proteins of orthohepadnaviruses suppress focus formation in REF
We used the oncogene complementation assay to characterize the pro-apoptotic activities of several orthohepadnaviral X genes which were cotransfected together with the oncogenes ras and myc (Figure 1a ). All wild-type X genes showed a high level of focus a b Figure 1 Focus suppression and transactivation by orthohepadnaviral X-proteins. (a) Focus suppression by orthohepadnaviral X-proteins. The oncogene complementation assay was used as previously described (Schuster et al., 2000) to characterize the pro-apoptotic activities of several orthohepadnaviral X genes which were all expressed under control of the CMV-promoter. The bars represent the results of three independent transfections. (b) Transactivation by orthohepadnaviral X proteins. The different expression constructs were used in luciferase assays with luciferase expression under control of the SV40 promoter/enhancer. Black bars: cotransfection with X-wild-type constructs; grey bars: cotransfection with X-expression negative constructs; open bars: cotransfection with C-terminal deletion mutants of X suppression which was similar to that of HBx in the case of GSHVx, ASHVx and WMHBx (black bars). Only WHx had a lower suppressive activity with about 32% of focus formation left. The expression negative mutant of WHx had almost no effect on focus formation (grey bars) and the same could be demonstrated for all carboxy-terminally truncated mutants which lacked the last 19 aa containing the conserved Kunitz-like domain (open bars). This is similar to the result of cotransfection of the corresponding C-terminal deletion mutant of HBx.
Transactivating and focus suppressive activities of orthohepadnaviral X-proteins correlate As we (Schuster et al., 2000) and others (Bergametti et al., 1999) could previously show a clear correlation between the transactivating and the pro-apoptotic activities of HBx, we wanted to know if the same was true for other orthohepadnaviral X-proteins. For this purpose we assessed the transactivation ability of the different X-expression constructs in a luciferase assay. The wild-type X-genes of GSHVx, ASHVx and WMHBx showed similar levels of transactivation as HBx, while the WHx wild-type construct displayed lower activity ( Figure 1b ). All C-terminal deletion mutants had almost no transactivating ability. Figure 2 shows a comparison of the transactivating and focus suppressive activities. Both activities were set as 100% for wild-type HBx and the activities of the other Xgenes were calculated relative to that for better representation. There was a good correlation of both functions for all orthohepadnaviral X-genes with the exception of wild-type WHx which displayed lower activities in both cases. Moreover, the pro-apoptotic and transcriptional activation activity of WHx appeared to diverge more compared to the X-proteins expressed by the other X-constructs.
X-like proteins of avihepadnaviruses act as transactivator in hepatocyte and fibroblast lines
An avihepadnaviral X-like ORF was first described for HHBV (Netter et al., 1997) and also found in the genomes of SGHBV (Chang et al., 1999) and STHBV (HJ Netter, S-F Chang, H Will, unpublished data). A very similar hidden ORF which does not use a conventional ATG start codon but whose expression has been demonstrated in vivo and in vitro also exists in DHBV . To investigate whether the ORFs of SGHBx, HHBx and STHBx show a similar transactivating ability as DHBx , the different expression constructs were tested in reporter gene assays as previously described . A schematic representation of the different ORFs is given in Figure 3a . Promoter elements from the AP1-gene or the SV40-enhancer were both stimulated to a similar level by cotransfection of the full-length constructs of all avihepadnaviral X-like ORFs and the N-terminal deletion mutant of DHBx. In contrast, the C-terminal deletion mutants of DHBx and SGHBx showed no transactivating effect ( Figure  3b ).
The transactivating function of HBx is often mediated by activation of the Raf-MAPK pathway (for review : Murakami, 1999) . A dependence of transactivation by DHBx on this signaling cascade has been demonstrated previously by cotransfection of a dominant-negative Raf mutant together with the CAT reporter plasmid under AP1-control known to be activated by this pathway . Using the same assay we could show that transactivation by full-length SGHBx, HHBx and STHBx is abolished in the presence of this dominant-negative Raf-mutant (Figure 3b ). These results demonstrate that the transactivating ability of all avihepadnaviral X-like ORFs studied so far is dependent on the Raf-MAPK pathway.
For better comparison with the activities of orthohepadnaviral X (Figure 1b) we repeated the transactivation assays for avihepadnaviral X in rodent fibroblasts (Figure 3c ). Not unexpectedly, the transcriptional activation activities of avihepadnaviral X were quite similar in the hepatocyte (Figure 3b ) and the fibroblast line (Figure 3c ).
X-like proteins of avihepadnaviruses suppress focus formation in REF
Whether the avihepadnaviral X genes also have proapoptotic properties was evaluated in the oncogene complementation assay (Figure 4) . Cotransfection of the two long DHBx and the other full-length X expression constructs together with the oncogenes ras and myc clearly resulted in suppression of focus formation. The strength of focus suppression was comparable to HBx in the case of HHBx and STHBx Apoptosis inhibitors partially relieve suppression of focus formation by avian X Several reports have shown that Bcl-2 can partially relieve apoptosis induction by HBx (Chirillo et al., 1997; Schuster et al., 2000) . We therefore tested whether the activities of avian X-proteins observed in REF could be partially reversed by inhibitors of apoptosis signaling cascades. We chose the strongest inducer of apoptosis induction, HHBx for these assays. Figure 5 shows that indeed Bcl-2 and E1B expression The oncogene complementation assay was used as previously described (Schuster et al., 2000) . Equal amounts of expression vectors for the cooperating oncogenes ras and myc were cotransfected together with expression constructs for avihepadnaviral X protein. The value for 100% focus formation was determined by cotransfection of empty control vector and the other values were calculated relative to that. The bars represent the mean values of three independent transfections Figure 5 Inhibitors of apoptosis Bcl-2 and E1B can partially relieve focus suppression by HHBV-X. Equal amounts of expression constructs for c-Ha-ras and c-myc were cotransfected with HHBV-X (black bars) or pBluescript (open bar) and expression vectors for the indicated apoptosis inhibitors. The bars represent the results of three independent transfections. -:pBluescript constructs could partially reverse the suppression of focus formation by HBx. Coexpression of the apoptosis inhibitors Bcl-2 and E1B doubled the number of foci. This partial relief was significant and in the range of two previous reports (Chirillo et al., 1997; Schuster et al., 2000) .
As with orthohepadnaviral X-constructs, avian Cterminal deletion mutants, DHBV-X28st and SGX19 had almost no transactivating and pro-apoptotic ability. Figure 6 shows a comparison of the transactivating and focus suppressive activities. Both activities were set as 100% for HHBx and the activities of the other avian X-genes were calculated relative to that for better representation. There was a good correlation of both functions for heron and stork X. For the X-genes of duck and snow goose the magnitude of transactivation and pro-apoptotic activity diverged more than already noticed with WHx (Figure 2) . However, both functions were concordantly completely abrogated with C-terminal deletions.
Discussion
Our data show that transactivating and pro-apoptotic properties of X are conserved in all analysed orthohepadnaviral X-genes. Only for WHx have there been previous reports which described either transactivating (Colgrove et al., 1989) or pro-apoptotic (Terradillos et al., 1998) properties. In an elegant study from C Transy's group the integrity of proapoptotic and transactivating functions of WHx had been shown to be essential for the infection of woodchucks (Sitterlin et al., 2000a) . Despite limited sequence homology to orthohepadnaviral X proteins and analysis of the avihepadnaviral X-protein functions in non-homologous mammalian cells, the transactivating and pro-apoptotic activities of avihepadnaviral X-proteins of stork and heron were comparable to that of the prototype human hepatitis B virus X protein. For duck and snow goose X the pro-apoptotic activity was conserved, although at a relatively low level. Why the transactivator and proapoptotic functions of duck and snow goose X diverge more than with the other avihepadnaviral x-proteins is not clear. Such a divergence of transactivator and apoptosis-influencing functions has been observed for WHx (Figure 2 ) and already been noticed in experiments with HBx-isolates of genotypes C and D (Elmore et al., 1997) . However, our knowledge and the number of isolates of avihepadnaviral x-like proteins is still limited. We cannot rule out the existence of unrecognized variants used in our experiments, nor can we exclude that duck and snow goose X have evolved farther away from mammalian pathways essential for the outcome of our experiments. More experiments on apoptosis induction in avian cell lines will be necessary to address this issue finally. Nevertheless, our data indicate that probably all X proteins target one or more evolutionarily conserved intracellular pathways in mammals and aves. It will be interesting to investigate if functional avian X proteins will also bind in vitro and in vivo to the cellular UVdamage associated repair protein UVDDBP-1 as shown for HBx (Becker et al., 1998; Lee et al., 1995; Sitterlin et al., 1997 Sitterlin et al., , 2000b and WHx (Sitterlin et al., 2000a) .
Similar to the extensively analysed HBx (reviewed in Murakami, 1999) our data indicate that C-terminal deletions comprising the conserved Kunitz-like domain abrogate the transactivating activity of ortho-and avihepadnaviral X proteins (Figures 1b and 3b, c) . As previously reported for HBx (Bergametti et al., 1999; Schuster et al., 2000; Sitterlin et al., 2000b) this loss of transcriptional activation functions comes along with a loss of pro-apoptotic functions for the truncated X proteins. Additionally, a natural variant of snow goose hepatitis X (SGx19) which is truncated by the last Cterminal 21 aa also had lost transactivating and proapoptotic functions. Therefore our results support and extend previous data that these two activities reside inseparably in the same domain of X.
In contrast to that, mutations (Runkel et al., 1993) or deletions (for review : Murakami, 1999) in the Nterminal 50 aa of human HBx have little effect on transactivation. However, these aminoterminal residues appear to be sufficient for transformation of immortalized cells (Gottlob et al., 1998b) . As HBx mutants found in HCC often have lost their transactivating and pro-apoptotic potential Tu et al., 2001) but retain the ability to abrogate p53-induced apoptosis (Huo et al., 2001) it seems possible that transformation and transactivation/ apoptosis are two separable and counteractive functions of HBx located in different domains. Because transactivation and induction of apoptosis are also (2000) which describes similar hydrophilicity profiles only for the C-terminal part of orthohepadnaviral X and full-length avihepadnaviral X proteins. Therefore, avihepadnaviral Xprotein probably lacks the transforming domain of HBx (Figure 7 ). This may partially explain the absence of HCC formation in hepadnavirus infected birds. For mammalian hosts, the specific properties of orthohepadnaviral X proteins together with high inflammatory activity and insertional mutagenesis by HBV-DNA may represent the important synergistic factors for the development of HCC.
Materials and methods
Cells, transfection and focus assay
Pregnant Fischer rats were obtained from Charles River Laboratories, Sulzberg, Germany. Primary embryo fibroblasts from d14 (post conception) embryos were prepared as described by (Land, 1995) .
For transfection 1.2610 6 REF were transfected by calcium phosphate precipitation (described in Ausubel et al. (1998) and thereafter the protocol of (Land, 1995) was followed. For each experiment the transfections were done in triplicate and repeated at least once. Most experiments have been performed with REF from at least two different preparations.
Equal amounts of expression vectors for the cooperating oncogenes ras and myc were cotransfected together with expression constructs for orthohepadnaviral X protein. The value for 100% focus formation was determined by cotransfection of empty control vector and the other values were calculated relative to that.
Reportergene assays
For luciferase assays in rodent fibroblasts 2.5 -3610 5 seeded Swiss 3T3 cells (from ECACC, maintained in DMEM medium with 10% FCS) were transfected with Lipofectamine (Life Technologies) using 0.02 mg of the SV40 enhancer driven luciferase-vector pGL2-control (Promega) and 0.1 mg of expression vector in a constant amount of 2 mg transfected total DNA (pBluescript-vector). After 48 h the transfected cells were harvested and lysed in Tris-buffer (250 mM, pH 7.8) by three cycles of freezing and thawing. Protein concentration of lysates was determined by BCA-assay (Pierce). 5 -10 mg of protein were used in the luciferase activity assay (Ausubel et al., 1998) . The results are shown as factors relative to basal luciferase expression and represent the mean values of three independent transfections. CATassays in HepG2 cells have been described before (Schuster et al., 2000) and were used the same way for Swiss 3T3 cells.
Constructs
All constructs were sequenced to verify correct insertion and to exclude PCR-induced mutations. The plasmids containing wt-HBx (pCX) and a mutant with two stop codons (pCXm) have been described previously (Schuster et al., 2000) . pCMV-HBxdl: Identical to pCX except for a C-terminal truncation of the last 19 aa of the HBx-gene. pCMV-WHX contains the complete X-ORF of WHV (subtype 8) in pCDNA3 (Invitrogen). pCMV-WHXdl contains the same gene but with a C-terminal deletion of the last 56 nucleotides. pCMV-WHXst is based on pCMV-WHX but unable to express X-protein due to a deletion of the first AUG and a frameshift downstream the second AUG. pCDNA6-WMHBX contains the complete X-ORF of the WMHBV (Lanford et al., 1998) . pcGSHVx and pcASHVx: Expression vectors for GSHVx and ASHVx were constructed using PCR-amplified fragments of the complete X-ORF from the vector pGSHV (Seeger et al., 1984) and the vector pks ASHV (Testut et al., 1996) respectively, which were inserted into the vector pCDNA3. pcGSHVx-del and pcASHV-del express a C-terminally truncated GSHVx or ASHVx in which the X-ORF is truncated by the last 19 aa.
Expression vectors for DHBx have been described previously . These constructs possess an artificial methionine as translational start codon generated by oligonucleotide-directed mutagenesis at the first amino acid of the X-like open reading frame. DHBV-X (pDHBV3-M1x) is the full-length construct with 118 aa, DHBV-X28 (pDHBV3-M28x) is N-terminally truncated by 28 aa, and DHBV-X28st (pDHBV3-M28x-stop) has a stop codon after the first 28 aa (Figure 3a) . For the expression of the other avian X proteins, plasmids containing full-length genome of SGHBV14 (Chang et al., unpublished data) , SGHBV15 (GeneBank accession number (AC): AF110997), SGHBV19 (AC: AF110998), HHBV4 (AC: M22056), and STHBV21 (Pult et al., 2001) were used as templates to amplify the corresponding X-fragments. All PCR products were cloned into the vector prk5 . These constructs use the natural ATG start codon. SGX14 is the full-length X-ORF construct from SGHBV14 (87 aa) (Chang et al., unpublished data) and differs by two amino acids from the sequence in SGX15. SGX19 contains the same sequence with a C-terminal truncation of the last 21 aa. The constructs from HHBV and STHBV contain an X-like ORF of 75 aa.
The description of the expression vectors for c-Ha-ras (pEJ-ras) and c-myc (Land et al., 1983) ; human Bcl-2 (bcl2-pSFFV-neo) (Cuende et al., 1993) , adenovirus E1B (pCMVE1B) (White et al., 1991) has been published.
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